×

Growth Reports

Growth Reports
Report Name

Glioma Therapeutics Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Disease (Astrocytoma, Oligoastrocytoma, Oligodendroglioma), By Treatment (Surgery, Chemotherapy, Radiation Therapy, Others), By Grade (Low Grade, High Grade), By End-User (Hospitals, Clinics, Ambulatory Surgical Centers), Countries and Companies Report

Glioma Therapeutics Market is projected to register a 9.5% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: October, 2024  |   Report Code: USD00022225  |   No. of Pages: 191

Glioblastoma Multiforme Therapeutics Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Treatment (Surgery, Radiation therapy, Chemotherapy, Targeted Therapy, Tumor Treating Field (TTF) Therapy, Immunotherapy), By Drug Class (Temozolomide, Bevacizumab, Lomustine, Carmustine Wafers, Others), By End-User (Hospitals, Clinics, Ambulatory Surgical Centers), Countries and Companies Report

Glioblastoma Multiforme Therapeutics Market is projected to register a 11.5% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: October, 2024  |   Report Code: USD00022224  |   No. of Pages: 195

Glaucoma Therapeutics Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Age Group (Child, Adult, Senior), By Gender (Male, Female), By Phase (Early Phase, Phase 1, Phase 2, Others), By Study Type, Interventional, Observational), By Drug Class (Bimatoprost, Travoprost, Latanoprost, Others), By Indication (Open Angle Glaucoma, Angle Closure Glaucoma, Secondary Glaucoma, Others), Countries and Companies Report

Glaucoma Therapeutics Market is projected to register a 4.5% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: October, 2024  |   Report Code: USD00022223  |   No. of Pages: 202

Geriatric Care Devices Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Product (Mobility Assistance Aids, Assistive Furniture, Bathroom Safety and Assistive Products, Communication Aids), By End-User (Hospitals, Elderly Nursing Homes, Homecare, Others), Countries and Companies Report

Geriatric Care Devices Market is projected to register a 7.5% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: October, 2024  |   Report Code: USD00022222  |   No. of Pages: 197

Genomics Biomarkers Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Type (Predictive Biomarkers, Prognostic Biomarkers ), By Indication (Oncology, Cardiovascular diseases, Neurological diseases, Renal Disorders, Others), By End-User (Hospitals, Diagnostic Centers, Others), Countries and Companies Report

Genomics Biomarkers Market is projected to register a 12.8% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: October, 2024  |   Report Code: USD00022221  |   No. of Pages: 201

General Laboratory Equipment Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Product (Instruments, Equipment, Laboratory Consumables), By End-User (Pharmaceutical, Healthcare, Academic, Industrial, Others), Countries and Companies Report

General Laboratory Equipment Market is projected to register a 7.8% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: October, 2024  |   Report Code: USD00022219  |   No. of Pages: 196

Gene Therapy for Inherited Genetic Disorders Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Type (Eye Disorders, Hematological Disorders, Central Nervous System Disorders, Muscular Disorders, Others), By Application (Hospital, Clinic, Research Institute, Others), Countries and Companies Report

Gene Therapy for Inherited Genetic Disorders Market is projected to register a 7.4% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: October, 2024  |   Report Code: USD00022218  |   No. of Pages: 199

Gene Therapy for CNS Disorders Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Indication (Alzheimer's Disease, Huntington's Disease, Parkinson's Disease, Batten Disease), By Type (Ex Vivo, In Vivo), By End-User (Hospitals, Speciality Clinics), Countries and Companies Report

Gene Therapy for CNS Disorders Market is projected to register a 24.5% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: October, 2024  |   Report Code: USD00022217  |   No. of Pages: 192

Gemcitabine Hydrochloride Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Product (Injection, Solution), By Type (Generic, Branded), By Indication (Breast Cancer, Non-small Cell Lung Cancer, Pancreatic Cancer, Others), Countries and Companies Report

Gemcitabine Hydrochloride Market is projected to register a 7.5% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: October, 2024  |   Report Code: USD00022215  |   No. of Pages: 200

Gel Permeation Chromatography Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Product (Gel Permeation Chromatography System, Detectors, Columns, Pumps ), By End-User (Pharmaceutical and biotechnology companies, Academic institutes and research laboratories, Others), Countries and Companies Report

Gel Permeation Chromatography Market is projected to register a 6.8% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: October, 2024  |   Report Code: USD00022214  |   No. of Pages: 194

USD Analytics

USD Analytics is a leading information and analytics provider for customers across industries worldwide.


Useful Links

Contact Us